The link you have selected will take you outside of ADMA Biologics corporate website. The site you will be entering is intended for U.S. audiences only. Do you wish to continue?
Hyperimmune donors with high-titer antibodies to select pathogens are identified.
Tailored plasma pools are derived from a unique blend of normal source plasma and plasma obtained from the selected donors.
A proprietary microneutralization assay quantitatively measures titer levels of neutralizing RSV antibodies in plasma donor samples.
*The following patents are applied to ASCENIV™ (immune globulin intravenous, human – slra): 9,107,906 composition 9,714,283 use 9,815,886 methods expiration 2035